These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 190768)

  • 21. The Friend virus genome: evidence for the stable association of MuLV sequences and sequences involved in erythroleukemic transformation.
    Bernstein A; Mak TW; Stephenson JR
    Cell; 1977 Sep; 12(1):287-94. PubMed ID: 902316
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythroleukemia induction by replication-competent type C viruses cloned from the anemia- and polycythemia-inducing isolates of Friend leukemia virus.
    MacDonald ME; Mak TW; Bernstein A
    J Exp Med; 1980 Jun; 151(6):1493-503. PubMed ID: 6247414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus.
    Ruan KS; Lilly F
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12202-6. PubMed ID: 1465459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of clonogenic and erythroleukemic cells by different helper virus pseudotypes of Friend spleen focus-forming virus.
    Mager DL; Bernstein A
    Virology; 1985 Mar; 141(2):337-41. PubMed ID: 3002024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine sarcoma virus defectiveness. Viral polymerase expression murine and nonmurine host cells transformed by S+L-type murine sarcoma virus.
    Peeples PT; Gerwin BI; Papageorge AG; Smith SG
    Virology; 1975 Oct; 67(2):344-55. PubMed ID: 52940
    [No Abstract]   [Full Text] [Related]  

  • 26. Friend erythroleukemia virus complex: role of viral components in modifying erythroid differentiation in mice.
    Fagg B; Ostertag W
    J Natl Cancer Inst; 1982 Mar; 68(3):457-60. PubMed ID: 6950173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: Spleen focus-forming virus in Friend and Rauscher leukemia virus preparations.
    Steeves RA
    J Natl Cancer Inst; 1975 Feb; 54(2):289-97. PubMed ID: 163329
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of erythroid target cells for Friend murine leukemia virus by intravenous pyran treatment.
    Schuller GB; Morahan PS
    J Natl Cancer Inst; 1979 May; 62(5):1257-60. PubMed ID: 286101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous replication of Friend virus complex (spleen focus-forming virus-lymphatic leukemia-inducing virus) in mouse embryo fibroblasts. Retention of leukemogenicity and loss of immunosuppressive properties.
    Eckner RJ
    J Exp Med; 1975 Oct; 142(4):936-48. PubMed ID: 1176891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
    Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
    J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical induction of focus-forming virus from nonproducer cells transformed by murine sarcoma virus.
    Aaronson SA
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3069-72. PubMed ID: 4332005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of sensitization with bacterial antigens on the replication of Friend spleen focus-forming virus.
    Flickinger JT; Gentile JM
    Can J Microbiol; 1971 Apr; 17(4):481-6. PubMed ID: 5553350
    [No Abstract]   [Full Text] [Related]  

  • 33. Helper activity of human leukemic tissue extracts for leukemia virus expression in mice.
    Steeves RA; Fjelde A; Mirand EA
    Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2391-5. PubMed ID: 4332810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helper virus is not required for in vitro erythroid transformation of hematopoietic cells by Friend virus.
    Hankins WD; Krantz SB
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5287-91. PubMed ID: 6933561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of helper virus replication in the presence of defective retrovirus.
    Anand R; Steeves RA; Lilly F
    Microbios; 1989; 58(235):71-82. PubMed ID: 2544787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helper specificity for retrieval of defective friend virus.
    Fieldsteel AH; Kurahara C; Dawson PJ
    Int J Cancer; 1975 Mar; 15(3):522-7. PubMed ID: 166938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of correlation between in vivo and in vitro assays for the detection of virus released from clones of Friend erythroleukemia cells.
    Bertolini L; Revoltella R; Bendinelli M; Friend C
    Int J Cancer; 1981 Jan; 27(1):67-72. PubMed ID: 6166581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice.
    Freedman HA; Lilly F
    J Exp Med; 1975 Jul; 142(1):212-23. PubMed ID: 1056976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial lipopolysaccharides as helper factors for Friend spleen focus-forming virus in mice.
    Steeves RA; Grundke-Lqbal I
    J Natl Cancer Inst; 1976 Mar; 56(3):541-6. PubMed ID: 1082940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited resistance to N- and B-tropic murine leukemia viruses in vitro: evidence that congenic mouse strains SIM and SIM.R differ at the Fv-1 locus.
    Ware LM; Axelrad AA
    Virology; 1972 Nov; 50(2):339-48. PubMed ID: 4344190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.